as of 2019, in every 100,000 people in the us, 22.1 are diagnosed with malignant melanoma davis et al.
according to davis et al., 812 of patients with melanoma have a family history of this neoplasm 1368.
8. epidemiological studies show that nearly 81 of patients with melanoma noticed nevi changes at the site of the malignant lesion davis et al., 1370.
for instance, melanoma patients present with cachexia and lymphadenitis davis et al.
similarly, 6471 of melanoma patients develop skin rashes or proliferative lesions following treatment davis et al.
malignant melanoma also increases the global burden of the disease since many resources are directed toward its treatment and management davis et al.